Do metastatic volumes measured in breast cancer patients with bone metastases correlate with the numbers of skeletal and extraskeletal events?

dc.authoridozturk, recep/0000-0002-6753-9321
dc.authoridYagar, Hilal/0000-0001-5544-0458
dc.contributor.authorYagar, Hilal
dc.contributor.authorAytekin, Mahmut Nedim
dc.contributor.authorDede, Didem Sener
dc.contributor.authorSendur, Mehmet Ali Nahit
dc.contributor.authorOzturk, Recep
dc.contributor.authorYalcin, Buelent
dc.date.accessioned2024-11-07T13:34:27Z
dc.date.available2024-11-07T13:34:27Z
dc.date.issued2024
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractObjectives: The study aimed to investigate the relationship between metastatic volume measurement, skeletal-related events, and survival in women diagnosed with breast cancer and bone metastases. Patients and methods: This retrospective study was conducted with 82 female breast cancer patients (mean age: 53 +/- 14.3 years; range, 23 to 87 years) diagnosed, treated, and followed up between January 2005 and December 2019. The collected data included information on metastasis sites and the presence of skeletal-related events. Metastatic volume was measured in two ways: the number of metastases (high to low) and their localization (the first, second, and third groups). The first group consisted of vertebrae, ribs, sternum, and calvarial bones; the second group included scapula, clavicle, proximal humerus, and proximal femur regions; the third group consisted of femur and humerus diaphyseal and distal regions, as well as metastasis regions in other long bones. Results: Sixty-three (76.8%) patients were diagnosed with ductal carcinoma. Half of the patients had bone metastases at the time of initial diagnosis, while 62 (75.6%) experienced skeletal-related events, with at least three events occurring in 30 (36.6%) patients. Bone pain was the most common skeletal-related event. No correlation was found between metastatic volume measurement based on the localization of bone metastases and the number of bones and the occurrence of skeletal-related events (p>0.05 for each). Patients' survival time spanned from one to 231 months (median: 56.8 months) from their first diagnosis. Patients with high metastatic volume, those in the third group, those whose pelvis and lung were involved, and elderly patients had a shorter survival time (p<0.05 for each). Conclusion: The study indicates that measuring metastatic volume may be a critical factor in evaluating the survival of breast cancer patients with bone metastases. Future prospective and randomized controlled studies can explore the potential of this measurement to create practical clinical tools.
dc.identifier.doi10.52312/jdrs.2023.1333
dc.identifier.endpage111
dc.identifier.issn2687-4792
dc.identifier.issue1
dc.identifier.pmid38108171
dc.identifier.scopus2-s2.0-85180383986
dc.identifier.scopusqualityQ2
dc.identifier.startpage105
dc.identifier.trdizinid1227231
dc.identifier.urihttps://doi.org/10.52312/jdrs.2023.1333
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1227231
dc.identifier.urihttps://hdl.handle.net/11480/15982
dc.identifier.volume35
dc.identifier.wosWOS:001099916400001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTurkish Joint Diseases Foundation
dc.relation.ispartofJoint Diseases and Related Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241106
dc.subjectBone metastasis
dc.subjectbreast cancer
dc.subjectmetastatic volume
dc.subjectskeletal
dc.titleDo metastatic volumes measured in breast cancer patients with bone metastases correlate with the numbers of skeletal and extraskeletal events?
dc.typeArticle

Dosyalar